Sarcopenia
- PMID: 29224698
- PMCID: PMC5768235
- DOI: 10.1016/j.berh.2017.11.007
Sarcopenia
Abstract
Sarcopenia is a condition that is characterized by loss of muscle mass, muscle strength and muscle functional impairment with ageing. The definition of sarcopenia has been through various permutations; however, an enormous recent breakthrough is the inclusion of the condition in the ICD-10 classification of diseases. This chapter covers the background issues regarding definition before describing the epidemiology of the disease according to human and environmental factors. It then provides a practical guide for the assessment of sarcopenia in a clinical setting and finishes with advice on present treatment and the exciting frontiers of future therapies.
Keywords: Ageing; Function; Muscle; Sarcopenia; Strength.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Conflict of interest statement
None to declare
Figures




References
-
- Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52(1):80–5. - PubMed
-
- Cao L, Morley JE. Sarcopenia Is Recognized as an Independent Condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) Code. J Am Med Dir Assoc. 2016;17(8):675–7. - PubMed
-
- Westbury LD, PV R, Syddall HE, Sanchez-Santos MT, Dennison EM, Robinson SM, Cooper C. Economic burden associated with sarcopenia: estimations from an English cohort study. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; Florence, Italy. 2017.
-
- Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med. 2001;137(4):231–43. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources